Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Team Grant: Bone Health - LOI

University of Alberta

$9,600.00

Quantitative Evaluation of Spatial Mineralization in the Context of Bone Disease and Drug Treatment

EF 2011-12

Résumé
When assessing the health of the skeleton, measures of bone form (anatomy) and function (physiology) are of critical importance. Non-invasive assessment of bone form is possible through established imaging methods such as X-rays and bone density scans. Alternatively, functional assessment requires invasive procedures which provide only very general information (e.g. blood tests) or very specific information (e.g. biopsies). To date, we have no non-invasive capacity to assess physiological aspects of bone health without the use of radioactive tracers. This is a significant limitation as the physiological process of bone turnover (remodeling) lies at the root of many diseases such as osteoporosis. The effects of remodeling are not entirely independent of bone form and imbalances in this process can lead to changes that impact clinical imaging measurements such as density. This issue is further complicated by the fact that some drugs/supplements utilized to combat bone disease are taken up by newly forming bone tissue. This alters chemical composition which, in turn, can alter clinical measures related to density. A key example is unregulated over-the-counter strontium supplements which are readily available in Canada. Our objective is to develop and apply novel non-invasive imaging techniques to track the distribution of materials such as strontium within animal models of bone disease and to determine their impact on bone density and strength. This will be achieved, in part, through the use of Canada's national synchrotron facility - the Canadian Light Source. The significance of this research is twofold. First, it will provide a new means of tracking physiological changes in bone which can be combined with anatomical information to achieve a more comprehensive understanding the role of remodeling in bone disease. Second, it will provide an improved means of investigating how variation in the chemical composition of bone impacts clinical assessments.
Programme
Team Grant: Bone Health - LOI
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
230382
Name
Doschak Michael R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Team Grant: Bone Health - LOI
Projecttitle
Quantitative Evaluation of Spatial Mineralization in the Context of Bone Disease and Drug Treatment
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$9,600
Cihrequipment2
$0
Programname2
Team Grant: Bone Health - LOI
Keyworddelim
Biomechanics; Bone; Bone Turnover; Elemental Analysis; Finite Element; Micro-Computed Tomography; Nanoindentation; Pharmacokinetics; Strontium; Synchrotron
Abstract
When assessing the health of the skeleton, measures of bone form (anatomy) and function (physiology) are of critical importance. Non-invasive assessment of bone form is possible through established imaging methods such as X-rays and bone density scans. Alternatively, functional assessment requires invasive procedures which provide only very general information (e.g. blood tests) or very specific information (e.g. biopsies). To date, we have no non-invasive capacity to assess physiological aspects of bone health without the use of radioactive tracers. This is a significant limitation as the physiological process of bone turnover (remodeling) lies at the root of many diseases such as osteoporosis. The effects of remodeling are not entirely independent of bone form and imbalances in this process can lead to changes that impact clinical imaging measurements such as density. This issue is further complicated by the fact that some drugs/supplements utilized to combat bone disease are taken up by newly forming bone tissue. This alters chemical composition which, in turn, can alter clinical measures related to density. A key example is unregulated over-the-counter strontium supplements which are readily available in Canada. Our objective is to develop and apply novel non-invasive imaging techniques to track the distribution of materials such as strontium within animal models of bone disease and to determine their impact on bone density and strength. This will be achieved, in part, through the use of Canada's national synchrotron facility - the Canadian Light Source. The significance of this research is twofold. First, it will provide a new means of tracking physiological changes in bone which can be combined with anatomical information to achieve a more comprehensive understanding the role of remodeling in bone disease. Second, it will provide an improved means of investigating how variation in the chemical composition of bone impacts clinical assessments.
Competitiondate
201104
Approvedterm2
1 yr 0 mth
Pinamesdelim
Doschak, Michael R; Boyd, Steven K; Chapman, Dean L; Cooper, David M; Jamali, Fakhreddin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $9,600~ $0~